Abstract:Thiazolidinedione-induced fluid retention results from two prominent mechanisms: increased distal tubular fluid reabsorption and adipose-specific increases in capillary permeability; the later mechanism requires activation of endothelial but not smooth muscle PPARγ as demonstrated by using conditional knockout mice (Yang et al. 63rd High Blood Pressure Research Conference. #063, 2009). The present study examined the role of microsomal prostaglandin E synthase-1 (mPGES-1) in TZD-induced capillary hyperperbeability in the adipose tissues. Following rosiglitazone (RGZ) treatment, remarkable COX-2 and mPGES-1 inductions were detected at day 1 and peaked at day 2 (COX-2:104-fold for mRNA and 98-fold for protein; mPGES-1: 2.5-fold for mRNA and 30-fold for protein) in parallel with a 64-fold increase in PGE2 production in apidydimal fat depot (AFD) but not in other tissues tested, and declined at day 14. Body weight gain (BWG) in response to RGZ in WT mice were 1.62 g on day 14. In contrast, the BWG in mPGES-1 KO mice was completely blocked on day 7 and was reduced by 60% on day 14. RGZ-treated WT mice exhibited a 60% increase in water content in the AFD, which was significantly attenuated in the KO mice. In parallel, the capillary perbeability in the adipose tissue, as assessed by Evans blue leakage assay, exhibited a 60% increase in WT mice after RGZ treatment. As compared with WT controls, the adipose capillary permeability in the KO mice was 60% less at baseline and 100% less after RGZ treatment. RGZ-induced fluid retention was further tested in mice lacking mPGES-1 in endothelium or smooth muscle generated respectively by crossing mPGES-1 floxed mice with Tie-2-Cre or SM22-Cre mice (termed EC KO or SM KO). In EC KO mice, TZD-induced capillary hyperpermeability in adipose tissue was completely abolished, associated with a 50% reduction of the BWG and complete blockade of PGE2 stimulation in the ADF, a phenotype analogous to that of endothelial PPARγ KO mice. In contrast, neither water content nor capillary permeability in the skeletal muscle was affected by RGZ treatment. Taken together, this study has defined endothelial mPGES-1 as a key mediator of TZD-induced adipose-specific capillary hyperperbeability and fluid retention.

Genetic or pharmacologic blockade of mPGES-2 attenuates renal lipotoxicity and diabetic kidney disease by targeting Rev-Erbα/FABP5 signaling

Emerging Protective Actions of PGC-1α in Diabetic Nephropathy

Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3 Beta Reinforces the Nrf2 Antioxidant Defense Against Podocytopathy

PGC-1α Ameliorates Kidney Fibrosis in Mice with Diabetic Kidney Disease Through an Antioxidative Mechanism.

Targeting mPGES-2 to protect against acute kidney injury via inhibition of ferroptosis dependent on p53

PPARγ Agonist Rosiglitazone Suppresses Renal Mpges-1/Pge2 Pathway in Db/db Mice

PGC1-α in diabetic kidney disease: unraveling renoprotection and molecular mechanisms

GLP-1RA Improves Diabetic Renal Injury by Alleviating Glomerular Endothelial Cells Pyrotosis Via RXRα/circ8411/miR-23a-5p/ABCA1 Pathway

Molecular mechanism of ectopic lipid accumulation induced by methylglyoxal via activation of the NRF2/PI3K/AKT pathway implicates renal lipotoxicity caused by diabetes mellitus

mPGES-2 blockade antagonizes β-cell senescence to ameliorate diabetes by acting on NR4A1

COX-2 but not mPGES-1 contributes to renal PGE2 induction and diabetic proteinuria in mice with type-1 diabetes.

Metabolic reprogramming by N-acetyl-seryl-aspartyl-lysyl-proline protects against diabetic kidney disease

8-LB: Adipocyte-Derived ANGPTL2 Regulates Abnormal Lipid Metabolism and Inflammation through PirB in Diabetic Kidney Disease

Proteomic analysis of kidney and protective effects of grape seed procyanidin B2 in db/db mice indicate MFG-E8 as a key molecule in the development of diabetic nephropathy.

Simultaneous blockade of VEGF-B and IL-17A ameliorated diabetic kidney disease by reducing ectopic lipid deposition and alleviating inflammation response

P2X7R/AKT/mTOR Signaling Mediates High Glucose-Induced Decrease in Podocyte Autophagy

Blockade of HMGB1 Attenuates Diabetic Nephropathy in Mice

Abstract 307: Endothelial Mpges-1 Mediates Thiazolidinedione-Induced Adipose-Specific Capillary Hyperpermeability and Fluid Retention

PPARγ and PGC-1α activators protect against diabetic nephropathy by suppressing the inflammation and NF-κB activation

Geniposide Improves Diabetic Nephropathy by Enhancing ULK1-Mediated Autophagy and Reducing Oxidative Stress through AMPK Activation

Glucagon-like peptide-1 alleviates diabetic kidney disease through activation of autophagy by regulating AMP-activated protein kinase-mammalian target of rapamycin pathway